Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Clinical Therapeutics
|
December 1, 2001
Considerations for optimal iron use for anemia due to chronic kidney disease
J Q Hudson, T J Comstock
Therapeutic Drug Monitoring
|
January 1, 1988
Temperature dependence of phenytoin-protein binding in serum: effects of uremia and hypoalbuminemia
T B Allison, T J Comstock
The American Journal of the Medical Sciences
|
October 1, 1989
Pseudoephedrine accumulation in renal failure
D A Sica, T J Comstock
Clinical Pharmacology and Therapeutics
|
January 1, 1978
Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias
R E Kates, T D Sokoloski, T J Comstock
Journal of Pharmaceutical Sciences
|
February 1, 1978
Rapid high-pressure liquid chromatographic determination of quinidine and dihydroquinidine in plasma samples
R E Kates, D W McKennon, T J Comstock
Clinical Pharmacy
|
January 1, 1983
Severe amitriptyline intoxication and the use of charcoal hemoperfusion
T J Comstock, W A Watson, T A Jennison
Nephron
|
January 1, 1989
Ranitidine bioavailability and disposition kinetics in patients undergoing chronic hemodialysis
T J Comstock, D A Sica, A Harford, et al.
Therapeutic Drug Monitoring
|
January 1, 1987
A comparative bioavailability study of carbamazepine tablets and a chewable tablet formulation
B Maas, W R Garnett, J M Pellock, et al.
Epilepsia
|
July 1, 1986
Single dose comparison of the relative bioavailability of phenytoin suspension and extended capsules
W E Fitzsimmons, W R Garnett, T J Comstock, et al.
The Annals of Pharmacotherapy
|
June 14, 2000
Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessment
G R Matzke, W L St Peter, T J Comstock, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Clinical Therapeutics
|
December 1, 2001
Considerations for optimal iron use for anemia due to chronic kidney disease
J Q Hudson, T J Comstock
Therapeutic Drug Monitoring
|
January 1, 1988
Temperature dependence of phenytoin-protein binding in serum: effects of uremia and hypoalbuminemia
T B Allison, T J Comstock
The American Journal of the Medical Sciences
|
October 1, 1989
Pseudoephedrine accumulation in renal failure
D A Sica, T J Comstock
Clinical Pharmacology and Therapeutics
|
January 1, 1978
Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias
R E Kates, T D Sokoloski, T J Comstock
Journal of Pharmaceutical Sciences
|
February 1, 1978
Rapid high-pressure liquid chromatographic determination of quinidine and dihydroquinidine in plasma samples
R E Kates, D W McKennon, T J Comstock
Clinical Pharmacy
|
January 1, 1983
Severe amitriptyline intoxication and the use of charcoal hemoperfusion
T J Comstock, W A Watson, T A Jennison
Nephron
|
January 1, 1989
Ranitidine bioavailability and disposition kinetics in patients undergoing chronic hemodialysis
T J Comstock, D A Sica, A Harford, et al.
Therapeutic Drug Monitoring
|
January 1, 1987
A comparative bioavailability study of carbamazepine tablets and a chewable tablet formulation
B Maas, W R Garnett, J M Pellock, et al.
Epilepsia
|
July 1, 1986
Single dose comparison of the relative bioavailability of phenytoin suspension and extended capsules
W E Fitzsimmons, W R Garnett, T J Comstock, et al.
The Annals of Pharmacotherapy
|
June 14, 2000
Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessment
G R Matzke, W L St Peter, T J Comstock, et al.
Page
of 2